Cargando…

Impact of changing reimbursement criteria on the use of fluoroquinolones in Belgium

OBJECTIVES: The criteria for the reimbursement of fluoroquinolones changed in Belgium on 1 May 2018. This study aims to quantify the difference in fluoroquinolone use after this change, and to assess the timing and persistence of this effect, both in terms of total reimbursed fluoroquinolone use and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vermeulen, Helene, Coenen, Samuel, Hens, Niel, Bruyndonckx, Robin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446932/ https://www.ncbi.nlm.nih.gov/pubmed/34374778 http://dx.doi.org/10.1093/jac/dkab255

Ejemplares similares

Impact of the COVID-19 pandemic on community antibiotic consumption in the EU/European Economic Area: a changepoint analysis
por: Vermeulen, Helene, et al.
Publicado: (2023)

Antimicrobial Drug Use and Macrolide-Resistant Streptococcus pyogenes, Belgium
por: Van Heirstraeten, Liesbet, et al.
Publicado: (2012)

Analysing the trend over time of antibiotic consumption in the community: a tutorial on the detection of common change-points
por: Bruyndonckx, Robin, et al.
Publicado: (2021)

Respiratory syncytial virus and influenza virus infection in adult primary care patients: Association of age with prevalence, diagnostic features and illness course
por: Bruyndonckx, Robin, et al.
Publicado: (2020)

Reimbursement of orphan drugs in Belgium: what (else) matters?
por: Picavet, Eline, et al.
Publicado: (2014)

Consumption of antibiotics in the community, European Union/European Economic Area, 1997–2017: data collection, management and analysis
por: Bruyndonckx, Robin, et al.
Publicado: (2021)

Consumption of cephalosporins in the community, European Union/European Economic Area, 1997–2017
por: Versporten, Ann, et al.
Publicado: (2021)

Consumption of quinolones in the community, European Union/European Economic Area, 1997–2017
por: Adriaenssens, Niels, et al.
Publicado: (2021)

Consumption of macrolides, lincosamides and streptogramins in the community, European Union/European Economic Area, 1997–2017
por: Adriaenssens, Niels, et al.
Publicado: (2021)

Consumption of penicillins in the community, European Union/European Economic Area, 1997–2017
por: Bruyndonckx, Robin, et al.
Publicado: (2021)

Quality appraisal of antibiotic consumption in the community, European Union/European Economic Area, 2009 and 2017
por: Adriaenssens, Niels, et al.
Publicado: (2021)

Consumption of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in the community, European Union/European Economic Area, 1997–2017
por: Versporten, Ann, et al.
Publicado: (2021)

Consumption of antibiotics in the community, European Union/European Economic Area, 1997–2017
por: Bruyndonckx, Robin, et al.
Publicado: (2021)

The Effect of Amoxicillin in Adult Patients Presenting to Primary Care with Acute Cough Predicted to Have Pneumonia or a Combined Viral-Bacterial Infection
por: Bruyndonckx, Robin, et al.
Publicado: (2021)

The impact of national and international travel on spatio-temporal transmission of SARS-CoV-2 in Belgium in 2021
por: Nguyen, Minh Hanh, et al.
Publicado: (2023)

Change-points in antibiotic consumption in the community, European Union/European Economic Area, 1997–2017
por: Bruyndonckx, Robin, et al.
Publicado: (2021)

Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up
por: Litzroth, Amber, et al.
Publicado: (2019)

Change in COVID19 outbreak pattern following vaccination in long-term care facilities in Flanders, Belgium
por: Crèvecoeur, Jonas, et al.
Publicado: (2022)

Dynamics of HPV vaccination initiation in Flanders (Belgium) 2007-2009: a Cox regression model
por: Lefevere, Eva, et al.
Publicado: (2011)

Accessibility to cochlear implants in Belgium: State of the art on selection, reimbursement, habilitation, and outcomes in children and adults
por: De Raeve, Leo, et al.
Publicado: (2013)

The impact of regular school closure on seasonal influenza epidemics: a data-driven spatial transmission model for Belgium
por: Luca, Giancarlo De, et al.
Publicado: (2018)

Evaluation of Fluoroquinolone Resistance in Clinical Avian Pathogenic Escherichia coli Isolates from Flanders (Belgium)
por: Temmerman, Robin, et al.
Publicado: (2020)

Hepatitis B virus prevalence and risk factors in hard-to-reach Turkish population living in Belgium: A protocol for screening
por: Koc, Özgür M., et al.
Publicado: (2019)

Mining social mixing patterns for infectious disease models based on a two-day population survey in Belgium
por: Hens, Niel, et al.
Publicado: (2009)

Integrating public preferences into national reimbursement decisions: a descriptive comparison of approaches in Belgium and New Zealand
por: Leopold, Christine, et al.
Publicado: (2020)

Changes in Medicare Reimbursement in Colorado: Impact on Physicians' Economic Behavior
por: Rice, Thomas, et al.
Publicado: (1982)

Palivizumab reimbursement criteria and neonatal RSV hospitalisation: a regional retrospective review
por: Belleudi, Valeria, et al.
Publicado: (2021)

The impact of Regional co-payment and National reimbursement criteria on statins use in Italy: an interrupted time-series analysis
por: Damiani, Gianfranco, et al.
Publicado: (2014)

Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, Belgium
por: Koc, Özgür M., et al.
Publicado: (2020)

Key performance indicators of COVID-19 contact tracing in Belgium from September 2020 to December 2021
por: Kremer, Cécile, et al.
Publicado: (2023)

Serial Intervals for SARS-CoV-2 Omicron and Delta Variants, Belgium, November 19–December 31, 2021
por: Kremer, Cécile, et al.
Publicado: (2022)

Decision-making criteria for medicine reimbursement in Slovenia: an expert panel discussion
por: Detiček, Andreja, et al.
Publicado: (2018)

The Belgian policy of funding antimicrobial stewardship in hospitals and trends of selected quality indicators for antimicrobial use, 1999–2010: a longitudinal study
por: Lambert, Marie-Laurence, et al.
Publicado: (2015)

Rethinking Screening Intensity in Terms of Reducing Prevalence or Increasing Selection Pressure for the Emergence of Resistant Gonorrhea: A Modeling Study of Men Who Have Sex With Men in Belgium
por: Tsoumanis, Achilleas, et al.
Publicado: (2023)

Clinical and economic impact of changing reimbursement criteria for statin treatment among patients with type 2 diabetes mellitus in South Korea
por: Kim, Siin, et al.
Publicado: (2022)

Amoxicillin for acute lower respiratory tract infection in primary care: subgroup analysis by bacterial and viral aetiology
por: Bruyndonckx, R., et al.
Publicado: (2018)

Systemic fluoroquinolone prescriptions for hospitalized children in Belgium, results of a multicenter retrospective drug utilization study
por: Meesters, Kevin, et al.
Publicado: (2018)

Influenza epidemic surveillance and prediction based on electronic health record data from an out-of-hours general practitioner cooperative: model development and validation on 2003–2015 data
por: Michiels, Barbara, et al.
Publicado: (2017)

Characteristics of the antibiotic regimen that affect antimicrobial resistance in urinary pathogens
por: Catry, Boudewijn, et al.
Publicado: (2018)

Outdated criteria for drug plan reimbursement obstruct evidence-based care
por: Bayoumi, Ahmed, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vl34aufarq7149lht1qp4kn2qk